Vertex Pharmaceuticals on Pace for Largest Percent Increase Since ...

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $489.63, up $16.83 or 3.56% --Would be highest close since Oct. 17, 2024, when it closed at $498.73 --On pace for …

56%
OFF

Vertex Pharmaceuticals On Pace For Largest Percent Increase Since ...

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $489.63, up $16.83 or 3.56% --Would be highest close since Oct. 17, 2024, when it closed at $498.73 --On pace for …

morningstar.com

3%
OFF

Vertex Pharmaceuticals On Track For Record High Close — Data Talk

2 weeks from now

Jun 3, 2024 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $468.98, up $13.64 or 3% ... --On pace for largest percent increase since Dec. 13, 2023, when it rose 13.23% - …

morningstar.com

8%
OFF

Vertex Pharmaceuticals Up Over 8%, On Track For Record High …

2 weeks from now

Dec 13, 2023 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $388.00, up $30.27 or 8.46% ... --On pace for largest percent increase since Oct. 28, 2022, when it rose 9.03%

morningstar.com

8%
OFF

Why Is Vertex (VRTX) Up 15.8% Since Last Earnings Report?

2 weeks from now

Jun 5, 2024 · It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 15.8% in that time frame, outperforming the S&P 500.

yahoo.com

8%
OFF

Vertex Pharmaceuticals Up Over 8%, On Track For Record High …

2 weeks from now

Feb 14, 2024 · Morningstar brands and products Company Get 7 Days Free

morningstar.com

9%
OFF

Vertex Hits All-time High As Nerve Pain Treatment ... - TradingView

2 weeks from now

Dec 13, 2023 · ** Shares of Vertex Pharmaceuticals VRTX rise as much as 8.9% to an all-time high of $389.57 ** Stock set for third straight session of gains with biggest one-day percentage …

tradingview.com

18%
OFF

Vertex Pharmaceuticals : Down Over 18%, On Pace For Largest …

2 weeks from now

Oct 15, 2020 · Vertex Pharmaceuticals Incorporated is currently at $221.93, down $49.53 or 18.25% -- Would be lowest close since March 27, 2020, when it closed at $217.24 -- On pace …

marketscreener.com

8%
OFF

Why Is Vertex (VRTX) Up 15.8% Since Last Earnings Report? - MSN

2 weeks from now

It has been about a month since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 15.8% in that time frame, outperforming the S&P 500. Will the …

msn.com

2%
OFF

Vertex (VRTX) Q3 Earnings On The Horizon: Analysts' Insights

2 weeks from now

Oct 30, 2024 · In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.13 per share, reflecting an increase of 1.2% …

nasdaq.com

$10.65
OFF

Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The ...

2 weeks from now

The company also raised the full-year revenue guidance range from $10.65-10.85 billion to $10.8-10.9 billion, a $100 million increase at the mid-point of the range and $90 million above the ...

seekingalpha.com

5%
OFF

Will Vertex Pharmaceuticals Stock See Higher Levels? - Forbes

2 weeks from now

Dec 10, 2021 · The stock price of Vertex Pharmaceuticals stock has seen a rise of 7.5% over the last month, while it is up 11% over the last ten trading days. The recent rise can be attributed …

forbes.com

6%
OFF

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug

2 weeks from now

Oct 24, 2024 · That would produce a 13.6% annual increase in the top line compared to today; that's quite significant, especially considering that the company has many other programs in its …

nasdaq.com

$508.38
OFF

Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst

2 weeks from now

Sep 19, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of $600.00, and a low estimate of $376.00.

nasdaq.com

76%
OFF

Vertex Pharmaceuticals On Pace For Largest Percent Decrease Since ...

2 weeks from now

Sep 3, 2024 · Vertex Pharmaceuticals Incorporated (VRTX) is currently at $477.26, down $18.63 or 3.76% --Would be lowest close since Aug. 15, 2024, when it closed at $472.00 --On pace …

morningstar.com

8%
OFF

What's Next For Vertex Pharmaceuticals Stock After An 8% Fall

2 weeks from now

[Updated: 6/14/2021] VRTX Stock Decline. The stock price of Vertex Pharmaceuticals (NASDAQ: VRTX) has seen an 8.1% drop over the last five trading days, after the company announced …

nasdaq.com

FAQs about Vertex Pharmaceuticals on Pace for Largest Percent Increase Since ... Coupon?

Is Vertex Pharmaceuticals stock on the rise?

The stock price of Vertex Pharmaceuticals stock has seen a rise of 7.5% over the last month, while it is up 11% over the last ten trading days. ...

Is Vertex Pharmaceuticals competing in new markets?

It'll almost certainly be competing in a few new markets. With a market capitalization of nearly $72 billion, Boston-based Vertex Pharmaceuticals ( VRTX -1.56%) is one of the world's biggest biopharma businesses. Yet, there's an incredibly small chance that you or anyone you've ever encountered has ever been treated with any of its drugs. ...

How much did Vertex Pharmaceuticals make in the third quarter?

The company's bottom line came in at $1.045 billion, or $4.01 per share. This compares with $1.035 billion, or $3.97 per share, in last year's third quarter. Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.143 billion or $4.38 per share for the period. ...

What happened to Vertex Pharmaceuticals (VRTX) stock?

The stock price of Vertex Pharmaceuticals (NASDAQ: VRTX) has seen an 8.1% drop over the last five trading days, after the company announced that it will discontinue the clinical trials for VX-864, an experimental treatment for the rare genetic disorder alpha-1 antitrypsin (AATD). ...

Should you buy Vertex Pharmaceuticals stock?

Answer: If you buy and hold Vertex Pharmaceuticals stock, the expectation is over time the near-term fluctuations will cancel out, and the long-term positive trend will favor you – at least if the company is otherwise strong. Overall, according to data and Trefis machine learning engine’s calculations, patience absolutely pays for most stocks! ...

How did vertex perform in Q1 2024?

Vertex reported first-quarter 2024 adjusted earnings per share of $4.76, which beat the Zacks Consensus Estimate of $4.10. Earnings increased 56% year over year, driven by higher product revenues, lower costs and a lower tax rate in the quarter. The company reported total revenues of $2.69 billion, comprising cystic fibrosis (CF) product revenues. ...